Several surveys from 2024 reveal data and characteristics of adult American cannabis usage and opinions.

Here, Scott Mazza, Founder of Vitality CBD, provides an overview on the potential benefits of minor cannabinoids including cannabinol (CBN) and cannabingerol (CBG).

Here, we discuss how to perform a validation, how to calculate the Standard Error of Prediction, and the best metric of calibration quality.

This article examines what rescheduling cannabis would involve, the implications for various sectors, and the potential roadblocks that could arise along the way.

In this segment of the cultivation education series, Adam Jacques and Zacariah L. Hildenbrand delve into croptober and the complexities that arise with outdoor, hybrid, and indoor cannabis cultivation.

The second part of this column will take a look at specific examples in the public domain of elemental contamination of cannabis consumer products, which shows that other elements are worthy of consideration and should be a part of the regulatory framework.

On November 5, 2024, Floridians will decide on Amendment 3, which proposes legalizing recreational cannabis. Former President Trump has stated support for this measure, aligning with his stance on state-level cannabis policies.

A look at how growers explore the possibilities of a more manageable operation as research about soil chemistry takes center stage.

The current framework for the lab testing of cannabis products enables product suppliers to use more favorable testing results to misrepresent less favorable products. This article presents an alternative framework that increases the costs, and thereby decreases the incentives to engage in such misrepresentations.

Inconsistent testing is a significant issue in the cannabis industry, contributing to fears about potency inflation and product safety. However, adopting cGMP compliance offers a clear solution by implementing standardized testing protocols, comprehensive batch testing, and rigorous third-party verification.

Listen to a Noid Factoid from Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC.

Aspergillus, a genus of mold that is abundant in our environment, has become a significant concern in the cannabis industry, particularly due to the health risks it poses to consumers. This mold, which thrives in various environments, including soil, decaying vegetation, and even in the air, is not inherently dangerous to healthy individuals. However, its presence in cannabis flowers, whether during cultivation, processing, or storage, can lead to severe health risks, especially for immunocompromised individuals.

This interview discusses the challenges in conducting unbiased research on the benefits of minor cannabinoids for pets, the potential synergistic effects of terpenes, and emerging research on using cannabinoid blends to treat conditions like epilepsy in dogs.

Here, Scott Mazza, Founder of Vitality CBD, discusses applying cannabidiol (CBD) in pets.

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.